Clinical trials
Phase 3 Genetic Diseases, Inborn trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vertex Pharmaceuticals Incorporated | 4 |
| PTC Therapeutics | 3 |
| Kastle Therapeutics, LLC | 2 |
| Pfizer | 2 |
| Regeneron Pharmaceuticals | 2 |
| BioMarin Pharmaceutical | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Forma Therapeutics, Inc. | 1 |
| Genzyme, a Sanofi Company | 1 |
| Kyntra Bio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 20 |
| Musculoskeletal Diseases | 7 |
| Genetic Diseases, X-Linked | 5 |
| Hematologic Diseases | 4 |
| Infant, Newborn, Diseases | 4 |
| Metabolic Diseases | 4 |
| Muscular Diseases | 4 |
| Muscular Disorders, Atrophic | 4 |
| Muscular Dystrophies | 4 |
| Muscular Dystrophy, Duchenne | 4 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.